{"id":92982,"date":"2022-12-22T00:00:00","date_gmt":"2022-12-22T00:00:00","guid":{"rendered":"http:\/\/medgoo.com\/index.php\/2022\/12\/22\/treatment-resistant-depression-common-and-costly\/"},"modified":"2022-12-28T21:33:38","modified_gmt":"2022-12-28T21:33:38","slug":"treatment-resistant-depression-common-and-costly","status":"publish","type":"post","link":"https:\/\/medgoo.com\/index.php\/2022\/12\/22\/treatment-resistant-depression-common-and-costly\/","title":{"rendered":"Treatment-Resistant Depression Common and Costly"},"content":{"rendered":"<h3>\n<p>Treatment-resistant depression episodes tied to more psychiatric comorbid conditions, health care utilization, self-harm, and all-cause mortality<\/p>\n<\/h3>\n<p><b>By Lori Solomon HealthDay Reporter<\/b><\/p>\n<p><b><\/b><\/p>\n<p>THURSDAY, Dec. 22, 2022 (HealthDay News) &#8212; Treatment-resistant depression (TRD) is associated with a heavy individual and societal burden, according to a study published online Dec. 14 in <em>JAMA Psychiatry<\/em>.<\/p>\n<p>Johan Lundberg, M.D., Ph.D., from the Karolinska Institutet in Stockholm, and colleagues estimated the burden of TRD in a large population covered by universal health care. Analysis included psychiatric and nonpsychiatric data from the Stockholm Major Depressive Disorder Cohort (2010 to 2017; including 158,169 unipolar MDD episodes in 145,577 patients) using the predefined criteria for TRD of three or more consecutive antidepressant treatments.<\/p>\n<p>The researchers found that 11 percent of MDD episodes fulfilled criteria for TRD, with a median time from the start of MDD episode to TRD of 552 days. TRD episodes had more inpatient bed-days (mean, 3.9 versus 1.3 days) and more lost workdays (mean, 132.3 versus 58.7 days) 12 months after the index date, compared with matched non-TRD episodes. Common comorbid conditions in TRD episodes included anxiety, stress, sleep disorder, and substance use disorder. TRD episodes were also associated with four times higher frequency of intentional self-harm. The all-cause mortality rate for patients with MDD and TRD episodes was 10.7 per 1,000 person-years at risk versus 8.7 per 1,000 person-years at risk among patients with MDD without TRD episodes (hazard ratio, 1.23). Severity of MDD at time of diagnosis was the most important prognostic factor for TRD.<\/p>\n<p>&#8220;The median time between initiation of new antidepressant treatments was longer than recommended in current treatment guidelines, suggesting room for more structured and timely depression care,&#8221; the authors write.<\/p>\n<p>Two authors disclosed financial ties to the pharmaceutical industry.<\/p>\n<p><a href=\"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/fullarticle\/2799488\" target=\"_blank\" rel=\"noopener\">Abstract\/Full Text<\/a><\/p>\n<p><i><\/i><\/p>\n<p><i>Copyright \u00a9 2022 <a href=\"https:\/\/www.healthday.com\/\" target=\"_new\" rel=\"noopener\">HealthDay<\/a>. All rights reserved.<\/i><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Treatment-resistant depression episodes tied to more psychiatric comorbid conditions, health care utilization, self-harm, and all-cause mortality<\/p>\n","protected":false},"author":6,"featured_media":93124,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[11],"class_list":["post-92982","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news"],"_links":{"self":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts\/92982","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/comments?post=92982"}],"version-history":[{"count":1,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts\/92982\/revisions"}],"predecessor-version":[{"id":93057,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts\/92982\/revisions\/93057"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/media\/93124"}],"wp:attachment":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/media?parent=92982"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/categories?post=92982"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/tags?post=92982"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}